ADP355 amide   Click here for help

GtoPdb Ligand ID: 14561

Synonyms: ADP 355-P-AlaNH2 [3] | ADP-355 amide | ADP355-NH2 | SEQ ID NO: 6 [WO2012142142] [3]
Immunopharmacology Ligand
Compound class: Peptide
Comment: ADP355 is an adiponectin receptor agonist. It is a peptide with sequence derived from the endogenous agonist adiponectin [3-4].
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@H](CO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@H](CO)C(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CC(=O)N)N
Isomeric SMILES CCC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@H](CO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@H](CO)C(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CC(=O)N)N
InChI InChI=1S/C53H80N12O14/c1-7-13-35(58-52(78)41-16-12-21-65(41)53(79)43(29(5)8-2)64-46(72)34(54)25-42(55)69)47(73)59-36(22-28(3)4)49(75)60-38(24-32-17-19-33(68)20-18-32)50(76)63-40(27-67)51(77)61-37(23-31-14-10-9-11-15-31)48(74)57-30(6)45(71)62-39(26-66)44(56)70/h9-11,14-15,17-20,28-30,34-41,43,66-68H,7-8,12-13,16,21-27,54H2,1-6H3,(H2,55,69)(H2,56,70)(H,57,74)(H,58,78)(H,59,73)(H,60,75)(H,61,77)(H,62,71)(H,63,76)(H,64,72)/t29-,30-,34+,35-,36-,37-,38-,39+,40+,41-,43-/m0/s1
InChI Key FAOICIJDRRZKCE-UBKMUEJXSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Barbalho SM, Méndez-Sánchez N, Fornari Laurindo L. (2023)
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review.
Biochem Pharmacol, 218: 115871. [PMID:37866803]
2. Kumar P, Smith T, Rahman K, Thorn NE, Anania FA. (2014)
Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice.
PLoS One, 9 (10): e110405. [PMID:25310107]
3. Otvos L, Surmacz E. (2012)
Adiponectin receptor agonists and methods of use.
Patent number: WO2012142142A2. Assignee: Temple Univ School of Medicine. Priority date: 11/04/2012. Publication date: 18/10/2012.
4. Wang H, Zhang H, Zhang Z, Huang B, Cheng X, Wang D, la Gahu Z, Xue Z, Da Y, Li D et al.. (2016)
Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury.
Sci Rep, 6: 19445. [PMID:26777428]